Drugs / GI148512
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01400932 | Jul 2011 → Apr 2012 | acne | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GI148512 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01400932 ↗ |
| Route | Topical | “when applied topically once daily for 12 weeks” NCT01400932 ↗ |